Pangali EV/EBITDA: Greenwich LifeSciences (GLSI)

The stability of Greenwich LifeSciences (GLSI) is underpinned by global patents for Flammeera immunotherapy and stringent certification requirements. This EV/EBITDA chart reflecting price action shows a value of 0.00. The growth in share prices is tied to the results of the final stage trials for the GP2 drug. Meanwhile, the reliability of component supplies is guaranteed by the use of specialized cold-chain transportation for biomaterials during vaccine development.

GLSI Greenwich LifeSciences Inc.: Nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 13.11.2026

GLSI (greenwichlifesciences.com): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:

Rega saham Greenwich LifeSciences, Inc|GLSI - Target konsensus

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Greenwich LifeSciences Inc|GLSI - Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Greenwich LifeSciences|GLSI - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku greenwichlifesciences.com|GLSI - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Total Utang marang Modal Greenwich LifeSciences|GLSI - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Greenwich LifeSciences, Inc.|GLSI - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Greenwich LifeSciences Inc|GLSI - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Greenwich LifeSciences|Rasio cepet greenwichlifesciences.com

- data bathi bisnis lan rasio investasi:

GLSI - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Greenwich LifeSciences|GLSI - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Greenwich LifeSciences|GLSI - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Greenwich LifeSciences Inc|GLSI - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Greenwich LifeSciences|GLSI - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan greenwichlifesciences.com|GLSI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Greenwich LifeSciences

Ringkesan analisis perusahaan:Greenwich LifeSciences, Inc GLSI

Sampel barang Greenwich LifeSciences, Inc.

For the biotechnology sector where Greenwich LifeSciences (GLSI) operates, the EV/EBITDA chart reflects business value relative to operational efficiency. This multiple compares the total enterprise value with earnings before interest and taxes over time. For a company in the clinical research stage, the sensitivity of this metric depends on grant funding and the future commercialization of immunotherapy. An upward trend in this indicator signals the capitalization of expectations, while simultaneously narrowing the financial margin of safety.

Pesaing utama

Pangali EV/EBITDA OLMA (Olema Pharma)|PBYI - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Zentalis Pharmaceuticals - Pangali EV/EBITDA|MGNX - Pangali EV/EBITDA|plustherapeutics.com (PSTV) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi operasional sadurunge panyusutan PCSA|EGRX (Eagle Pharmaceuticals Inc.) - Pangali EV/EBITDA